ICD-10 F17.201 (Nicotine dependence, unspecified, in remission) falls in Medicare's Tobacco Use chronic-condition class. In 2024, 740,654 Medicare providers had Tobacco Use patients in their panels — an estimated 32.9M panel patients nationally, from public CMS data.
The top 5 nationally, ranked by estimated Tobacco Use patients in their 2024 Medicare panel. Panel-prevalence estimate — these are providers whose patients carry this condition class, not providers who billed this exact code.
| # | Provider | Specialty | Location | Est. Tobacco Use patients | Panel share |
|---|---|---|---|---|---|
| 1 | David Chess, M.D. | Geriatric Medicine | Stratford, CT | 15,722 | 14% |
| 2 | Justin Poling, M.D. | Pathology | Nashville, TN | 13,234 | 9% |
| 3 | Wilfredo Blasini, M.D. | Pathology | Fort Myers, FL | 9,785 | 10% |
| 4 | Harvey Paley, M.D. | Otolaryngology | Encino, CA | 4,900 | 15% |
| 5 | Robyn Olney, M.D. | Pathology | Dallas, TX | 4,706 | 6% |
Ecological estimate from panel composition, weighted by Tobacco Use patient volume — talk-track context, not a clinical claim. Explore the full comorbidity map →
Prospect 811 turns a diagnosis into a call list: which providers see the condition, at what volume, in your exact territory, with phone numbers. $79/month, no contract, 14-day refund.
Start prospecting →